We aim to correlate point mutations in the androgen receptor gene with receptor phenotypes and with clinical phenotypes of androgen resistance. In two families, the external genitalia were predominantly female at birth, and sex-of-rearing has been female. Their androgen receptor mutation changed arginine-839 to histidine. In a third family, the external genitalia were predominantly male at birth, and sex-of-rearing has been male: their codon 839 has mutated to cysteine. In genital skin fibroblasts, both mutant receptors have a normal androgen-binding capacity, but they differ in selected indices of decreased affinity for 5 alpha-dihydrotestosterone or two synthetic androgens. In transiently cotransfected androgen-treated COS-1 cells, both mutant receptors transactivate a reporter gene subnormally. The His-839 mutant is less active than its partner, primarily because its androgen-binding activity is more unstable during prolonged exposure to androgen. Adoption of a nonbinding state explains a part of this instability. In four other steroid receptors, another dibasic amino acid, lysine, occupies the position of arginine-839 in the androgen receptor. Androgen receptors with histidine or cysteine at position 839 are distinctively dysfunctional and appear to cause different clinical degrees of androgen resistance.
Introduction
The androgen receptor (AR)' protein is an androgen-sensitive transcription factor. Androgen binding enables its DNA-binding androgen receptor; DHT, [1,2,4,5,6,7-3H] domain to recognize particular regulatory sequences of DNA (androgen-response elements) and thereby to increase or decrease the expression of certain target genes. In 1974 ( 1 ) several laboratories (2, 3) began to characterize the androgen-binding activities in the genital skin fibroblasts (GSF) of 46,XY humans with various clinical expressions of androgen resistance (insensitivity), on the presumption that they had mutant ARs. More recently, the cloning of the AR cDNA (4-7) and the application of derivative molecular techniques have permitted us (8) (9) (10) (11) (12) (13) (14) and others (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) to try to correlate specific germline lesions in the androgen-binding region of X-linked AR gene with various dysfunctional behaviors of the AR and with their clinical consequences for the affected subjects. The ultimate aim of such correlative studies is to elucidate the stereochemistry that imparts androgen-binding specificity to an AR and the contribution of an androgenic ligand to the transcriptional regulatory attributes of an A-R complex. In this paper, we describe three families that have alternative, single-nucleotide, missense mutations at the Arg-8392 codon in exon 7 of the androgen-binding domain of the AR gene ( Fig. 1 ).
Methods
Subjects and theirfamilies. 4308, the index subject in a black-American family, was described previously (28) . She was born with a single perineal urogenital orifice flanked by labioscrotal folds. With the aid of corrective surgery, she and an affected maternal aunt were reared as females. The properties of the specific androgen-binding activity in 4308's GSF (28) Androgen-binding activity in cultured cells. For GSF, specific androgen-binding activity, maximum androgen-binding capacity, the apparent equilibrium dissociation constant (Kd), the rate constant of dissociation (k), and theromstability of various A-R complexes or of the free AR were determined on monolayer cultures as described previously (29) . The same methods were used for COS-1 cells except that they were washed and lysed in 0. 5 
Results
Identification and restriction-site analysis of the mutations. By PCR amplification and direct sequencing of exons 1-8, we found the guanine to adenine transition responsible for Arg839His first in the GSF of subject 4308 and then in those of the half-sisters A.E.L./K.E.L. (Fig. 2) later found the cysteine to thyniine transition responsible for Arg839Cys in the brothers 335002/333203 (Fig. 2) . The ablation of a PvuI site by either substitution allowed us to prove maternal heterozygosity for the half-sisters A.E.L./K.E.L. (Fig.  3, top) and for the brothers 335002/333203 (Fig. 3, bottom) . 42 .5°C (Fig. 6 A) . In contrast, as previously shown for GSF, when the transfected COS-1 cells were first exposed to a temperature of 42.5°C in the presence of 100 ,uM cycloheximide and then measured for androgen-binding activity at various intervals, there was no appreciable difference between the thermostability of the normal receptor and either of the two mutant ARs (Fig. 6 B) . Fig. 7 A shows that in COS-1 cells treated with MB 6-80 h after cotransfection the Arg839His AR had a clear tendency to be less active in promoting transcription of the GH gene than the Arg839Cys AR and that both of them were less active than the normal hAR.
We also assessed stability of the normal and either type of mutant AR in COS-1 cells by measuring their androgen-binding activities during various intervals after transfection. Fig. 8 shows that the normal binding activity was stable, or relatively so, during prolonged (46-120 h) incubation at all MB concentrations tested, whereas both types of mutant activities were clearly unstable at the same MB concentrations. Again, the Arg839His mutant was inferior to the Arg839Cys. The approximate 50% difference between the 2-h binding activities at the beginning and the end of the prolonged exposure to MB reflects the transience of the transfections. In this respect, all three transfections behaved very similarly.
In another transfection experiment using only 3 nM MB (Fig. 9) , the normal and mutant androgen-binding activities were subjected to immunoblot analysis. As above, the 118-120-h binding activities were 40-50% of those in their 46-48-h counterparts, and their respective blot intensities were appropriate. As before (Fig. 8) , prolonged (46-120 h) incubation with MB caused cells with Arg839His to lose more (> 75%) of their starting binding activity than cells with Arg839Cys (50%). Under the same conditions, the cells with the wildtype hAR essentially maintained their initial androgen-binding activity. After prolonged MB incubation, the immunoreactivities of the wild-type hAR and both mutant forms increased relative to their respective androgen-binding activities. This implies that fractions of their respective pools of ARs were in a Hours at 42.50C non-androgen-binding state; it is evident that these fractions were greater for the mutants.
In Fig. 7 B, for each of three experiments, we replotted GH production (shown in aggregate in Fig. 7 A) against relative MB-binding activity during prolonged h) MB incubation. In two experiments, the normal and mutant receptors were indistinguishable; in the third, the differences were slight.
Discussion
In our initial report (28) on the partial androgen insensitivity syndrome in 4308, we noted that her GSF AR phenotype was distinctive; for instance, her DHT-receptor complexes had questionably increased 370C k values, yet the 420C k values for her MB-receptor complexes were clearly high. Many years later, we realized that 4308 and the unrelated half-sisters, A.E.L./K.E.L., shared not only the Arg839His AR but also a very similar GSF AR phenotype and predominantly female external genitalia. The broad phenotypic similarity in the two (Fig. 1) imply that the hAR must have Arg or Lys at position 839 to function normally. Our data also suggest that His-839 tends to disrupt the AR more than Cys-839 does: the former is likely to cause predominantly female external genitalia and a female sex-of-rearing; the latter is likely to cause predominantly male external genitalia and a male sex-of-rearing. The two unrelated individuals with Arg839Cys reported by others (25) also had partial Al with a male phenotype (Reifenstein syndrome) and, as we have found, in the GSF of the one tested, MBreceptor complexes had normal 370C k values. Others have found the Arg839His mutation in four unrelated individuals. All four had partial Al: two with a female phenotype (25, 27) , one with a male phenotype (25) , and one ambiguous (41) . Importantly, as we found, in the GSF from the one subject with a female phenotype tested, the AR had an increased k value for MB at 370C (25) . Remarkably, the GSF of the one with a male phenotype had almost unmeasurable androgen-binding activity, typical of subjects with complete Al (25) . This is a striking indication that "background" factors can mitigate the typical clinical expression of an AR mutation.
The fact that neither the His nor the Cys substitution of Arg-839 disrupts the AR sufficiently to cause complete Al is provocative, in light of information available on the same set of substitutions at two other Arg codons in the AR's androgenbinding domain. For instance, Arg773Cys disrupts the AR phenotype more than Arg773His (12), yet both cause complete Al exclusively (12, 24, 26), possibly because Arg-7734 is within an ultraconserved region of the androgen-binding domain. Contrarily, Arg854Cys has caused complete Al in three out of three subjects (25, 26, 42) , while Arg854His has caused partial Al in three out of four subjects (24, 25, 43), yet Arg-8545 is at the NH2-terminal limit of an 11-amino acid stretch that is absolutely identical among the members of the AR subfamily. The facts that Arg-839 is not within a highly conserved region of the androgen-binding domain and that neither Cys-839 nor His-839 causes complete Al indicate that Arg-839 is less important than Arg-773 or Arg-854 to the AR's androgen-binding properties. It is also noteworthy that Cys-839 appears to be less disruptive than His-839, whereas Cys-773 and Cys-854 appear to be more disruptive than His-773 and His-854, respectively. Perhaps this is because Cys-839 does not provoke a harmful disulphide bridge, whereas Cys-773 and Cys-854 do. This hypothesis is strengthened by the ligand-and temperature-restricted character of the moderately abnormal nonequilibrium rate constants of dissociation that we have observed in GSF carrying either of the present mutations. In the GSF of most subjects with complete Al due to missense mutations in their androgen-binding domains, these rate constants of dissociation are more abnormal absolutely and seldom ligand-or temperature-restricted ( 14).
Arg839Cys and Arg839His represent G:C --A:T transitions.
This reflects the tendency for cytosines at CpG dinucleotides to become thymines by methylation at carbon 5 and spontaneous deamination at carbon 4. Indeed, 9 out of 28 point mutations
